ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

  • Home
  • 2023 SIDP Annual Business Meeting and Reception

2023 SIDP Annual Business Meeting and Reception

  • 10 Oct 2023
  • (EDT)
  • Boston Convention and Exhibition Center

Registration


Registration is closed


2023 SIDP Annual Meeting

October 10, 2023

Boston Convention and Exhibition Center

415 Summer Street, Boston, MA 02210

Meeting Information: The meeting will be a virtual/live hybrid meeting this year with the live portion held at the Boston Convention and Exhibition Center in Boston, MA from 12:00-6:00 p.m. EST on October 10, 2023, one day prior to the start of the live IDWeek 2023 meeting (October 11-15). A reception including socialization, light appetizers, and beverages will immediately follow the meeting. Check-in will start at 11:00 AM EST, so book your flights accordingly! Please make every effort to register ahead of time so we have an accurate head count. You must register online by October 1, 2023 to avoid incurring a late fee. On-site registration will be permitted, but an additional late fee will be included in the cost.


2023 SIDP Annual Business Meeting and Lecture Series Agenda:

 Time

Description

 11:00 AM - 12:00 PM

Check-in

 12:00 - 1:15 PM

President’s Welcome

Business Meeting

Strategic Planning

Treasury report

 1:15 - 2:15 PM

Educational Session

MICs: Who Needs ‘Em? (No, Really-Who Needs Them?) A Debate

Show MICs: Navaneeth Narayanan, PharmD, MPH, BCIDP

Hide MICs: Caleb Rux, PharmD

 2:15 - 2:45 PM

Break and Snacks with Research Poster Presentations

Exhibit Hall

 2:45 - 3:45 PM

Educational Session

The wAIt is Over: Artificial Intelligence Applications in Antimicrobial Stewardship

Whitney Buckel, PharmD, BCIDP

Helen Newland, PharmD, BCPS, BCIDP

 3:45 - 4:30 PM

Keynote Address

Where is the Future of ID Pharmacy Headed?

Sebastian Hamilton, PharmD, MBA, RPh

 4:30 - 5:00 PM

Break and Snacks with Trainee/New Member Networking Bingo

Exhibit Hall

 5:00 - 5:30 PM

ID Trivia

Co-hosted by Monica Mahoney, PharmD, BCPS, BCIDP

& Douglas Slain, PharmD, BCPS

 5:30 - 6:00 PM

Awards

New Fellows

Installation of Incoming Board Members

Incoming President Remarks

 6:00 – 9:00 PM

Reception in Exhibit Hall – cocktails, beer, wine, appetizers


Meeting registration fees:


Online Registration

(through Oct 1)

On-site Registration

(Oct 10)

SIDP Members Meeting and/or Reception

Free

$50

Non-SIDP Members Meeting and Reception

$275

$325

Non-SIDP Members Reception only

$225

$275

Non-SIDP Members Meeting only

$100

$150

BCIDP/ACPE Credit: The SIDP Programs Committee and Board of Directors are excited to announce that we will be offering BCIDP and ACPE credit for the following topics at the Annual Meeting:

“MICs: Who Needs ‘Em? (No, Really-Who Needs Them?)”

“The wAIt is over: Artificial Intelligence Applications in Antimicrobial Stewardship”

Note, the cost for BCIDP credit for SIDP members is $10 per session and $20 per session for non-members (BCIDP fee payable online when completing the BCIDP credit process). ACPE credit is included in meeting registration costs.


MICs: Who Needs ‘Em?

(No, Really-Who Needs Them?)

1:15 pm -2:15 pm

Join us for this debate style session finding the balance between providing MICs to allow for dose optimization when possible while also preventing providers from selecting antibiotics strictly based on the numerical value of the MIC.

This activity will discuss the positive and negative aspects of reporting MICs. Alternative options will be discussed and participants will have an opportunity for Q&A at the end.

Learning Objectives:

At the completion of this activity, the participant will be able to:

  • Describe benefits of reporting minimum inhibitory concentrations (MICs) within susceptibility reports
  • Identify potential pitfalls of reporting MICs on susceptibility reports
  • Outline alternative options for MIC reporting to all-or-nothing approaches

Faculty:

Navaneeth Narayanan, PharmD, MPH, BCIDP

Clinical Associate Professor

Rutgers University Ernest Mario School of Pharmacy

Infectious Diseases Clinical Pharmacist

Robert Wood Johnson University Hospital - New Brunswick


Caleb Rux, PharmD, BCIDP

Clinical Pharmacist II, Infectious Diseases

Yale New Haven Hospital


UAN: 0672-0000-23-044-L01-P

CPE credit: 1 contact hour (0.1 CEU)

Type of activity: Knowledge


The wAIt is over: Artificial Intelligence Applications in Antimicrobial Stewardship

2:45 pm – 3:45 pm

With the advent of artificial intelligence (AI), clinicians are asking how we can use AI to improve patient care. Predictive software is currently being used to calculate individual patients’ risk for being infected with a drug-resistant pathogen. These models can help to create a real-time patient-specific antibiogram to assist with empiric drug choice based on historical patient, treatment, and microbiologic data. Pioneers in this area are validating these tools in Enterococcal bacteremia and showing promising results regarding time to appropriate antibiotic therapy for Gram-negative bacteremia.

This activity will discuss machine learning and artificial intelligence and how it can be applied to antimicrobial stewardship. Various uses will be discussed throughout the session, with an opportunity for Q&A at the end.

Learning Objectives:

At the completion of this activity, the participant will be able to:

  • Describe machine learning and artificial intelligence
  • Outline uses of machine learning to improve efficiency of Antimicrobial Stewardship Programs (ASP) to provide patient-specific therapy including audit and feedback, resistance identification, predictive resistance, patient-specific antibiotic treatment, and pathogen whole genome sequencing
  • Discuss application of AI in ASPs in infection diagnosis including prediction of urinary tract and upper respiratory tract infections

Faculty:

Helen Newland, PharmD, BCPS, BCIDP

Program Director, Antimicrobial Stewardship Coordinator

BJC HealthCare

Whitney Buckel, PharmD, BCIDP

System Antimicrobial Stewardship Pharmacist Manager

Associate Professor of Research

Intermountain Health, Pharmacy Services


UAN: 0672-0000-23-043-L01-P

CPE credit: 1 contact hour (0.1 CEU)

Type of activity: Knowledge

Target Audience:

These activities have been designed for pharmacists and board-certified infectious diseases pharmacists (BCIDPs) seeking to update their knowledge and skills related to infectious diseases.

Activity Fees:

The cost for BCIDP credit for SIDP members is $10 per session and $20 per session for non-members (BCIDP fee payable online when completing the BCIDP credit process). ACPE credit is included in the meeting registration costs.

Accreditation:

Pharmacist

The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

To receive CE credit, participants must attend the session, complete an online post-test assessment and an activity evaluation. Proof of completion will be submitted to NABP CPE Monitor.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Participants are responsible for verifying credits were transferred successfully to your NABP eProfile account before the ACPE 60-day deadline. After the 60 day deadline, SIDP will no longer be able to report your credit(s) for this activity.

BCIDP

The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certified infectious diseases pharmacist (BCIDP) credit. A BCIDP statement of credit will be issued online upon successful completion of a post-test and online evaluation. The post-test must be successfully completed in only one attempt. No partial credit will be given. BCIDP accreditation begins 10/10/2023 for this activity and is available for one year from this date.

Recertification Criteria for Infectious Diseases Pharmacy: BCIDP recertifying via continuing education are required to earn 100 hours of continuing education credit provided by the joint program offered by the Society of Infectious Diseases Pharmacists (SIDP), American College of Clinical Pharmacy (ACCP) and/or the American Society of Health-System Pharmacists (ASHP). Infectious Diseases Pharmacy Specialty Recertification Courses offered by any of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle. Candidates should note that there are expiration dates associated with earning BPS recertification credit. BPS will only award recertification credit for modules based on the completion and submission date of the post-test assessment. For example, a module completed and submitted on October 20 of a particular year will only be credited for that year, even if the due date of the post-test is in January of the following year. View all recertification criteria on the BPS website at https://www.bpsweb.org/recertification/recertification-by-continuing-education

Funding:

This activity is provided by SIDP. No external funding was received for these educational sessions.

Disclosures:

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, SIDP asks all individuals involved in the development and presentation of CE activities to disclose all relevant financial relationships with ineligible companies. All relevant financial relationships are mitigated prior to the CE activity. CE disclosures will be provided prior to the start of the CE activity.

Disclaimer:

Faculty members are asked to disclose when any unlabeled/investigational use of pharmaceuticals and devices is being discussed. This activity is intended for educational purposes and should not be used as a substitute for care or advice from a professional. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SIDP.

The planners and faculty of this continuing education activity have made all reasonable efforts to ensure the accuracy of the information presented in accordance with the latest available scientific knowledge at the time of publication. Healthcare professionals should verify all information and data with recommendations of other authorities before treating patients or employing any therapies described in this continuing education activity.



Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software